MENU
HLVX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
HilleVax (HLVX) Ownership - Who owns HilleVax?
HilleVax Inc is a clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 213-5054
Employees
90
Web
https://www.hillevax.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
104.71M
P/E Ratio
N/A
Total Cash
159.54M
Projected Growth
N/A
Total Debt
24.04M
Revenue
N/A
Risk (Beta)
0.92
Dividend Yield
N/A
Total Cash/Share
3.18
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
HLVX
Capitalization
105M
P/E Ratio
N/A
Risk (Beta)
0.92
Dividend Yield
N/A
Total Cash
160M
Total Cash/Share
3.18
Total Debt
24M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
151M
P/B Ratio
0.70
Cash Flow
N/A
Earnings
-2.15
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
25.32
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-100.93M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-43.20
Shares Held By Institutions
55.6M
Shares Outstanding - Current
50.1M
Total Liabilities
27.9M
Total Volume MTD
N/A
Value
1
Gain YTD
1.932
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 213-5054
Employees
90
Web
https://www.hillevax.com